PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-7.65%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-7.65%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Other current assets up to 5% yoy – slight increase. Howard Marks would confirm if these items remain genuinely short-term.
-5.46%
Declining current assets may signal efficient working capital or liquidity concerns. Benjamin Graham would investigate the composition of the decline.
13.35%
Net PP&E growth 10-20% yoy – strong investment in physical assets. Warren Buffett examines if returns on these assets meet the cost of capital.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Up to 5% yoy – slight expansion. Howard Marks would verify the purpose of these new or intangible assets.
2.60%
Growth 0-5% yoy – slight. Peter Lynch might see it as conservative expansion or replacement-level spending.
No Data
No Data available this quarter, please select a different quarter.
-5.18%
Declining total assets may signal asset sales or strategic downsizing. Seth Klarman would investigate the strategic rationale.
41.04%
AP up over 5% yoy – potential sign of delayed payments or aggressive working capital management. Philip Fisher demands clarity on vendor terms vs. revenue expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.09%
Above 15% yoy – a notable jump. Philip Fisher demands clarity on how short-term liabilities are managed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.41%
Above 10% yoy – large jump. Philip Fisher demands clarity on whether growth justifies the leverage.
4.74%
Up to 5% yoy – small issuance. Howard Marks asks if new capital is used productively.
-3.50%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
-4.99%
Declining AOCI may indicate reduced unrealized gains or currency losses. Howard Marks would see this as potentially reducing volatility.
No Data
No Data available this quarter, please select a different quarter.
-23.90%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
-5.18%
Declining total capital may indicate asset sales or poor capital allocation. Howard Marks would investigate strategic implications.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.42%
Above 5% yoy – net debt expansion. Philip Fisher demands clarity on the reason for higher leverage vs. cash.